The Veteran's appeal is being remanded for further development, including obtaining a precise date of cessation of treatment for his non-Hodgkin's Lymphoma and addressing the severity of any residual conditions. The claim of entitlement to TDIU will also be referred to the Compensation Service Director for extraschedular consideration.
The deciding factor: The Veteran's claims require additional development, including obtaining a precise date of cessation of treatment for his non-Hodgkin's Lymphoma and addressing the severity of any residual conditions. The claim of entitlement to TDIU will also be referred to the Compensation Service Director for extraschedular consideration.
- Claimed conditions
- Non-Hodgkin's Lymphoma
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- March 14, 2016
- Citation
- 1610150
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 1610150.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's service connection for leukemia, characterized as CLL, was improperly severed. Service connection for T-cell LGL leukemia is restored. The severance of service connection for NHL is upheld.
- Granted
The Board has restored a 100 percent rating for the Veteran's non-Hodgkin's lymphoma, effective April 1, 2025.
- Granted
The Veteran's SMC was granted at the intermediate level between 38 U.S.C. § 1114(m) and (n) due to additional disabilities including peripheral neuropathies, tinnitus, hearing loss, and lymphoma.
- Granted
The Veteran's non-Hodgkin's Lymphoma was granted a 100% rating effective February 8, 2019.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.